Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Apr 12.

Published in final edited form as: Catheter Cardiovasc Interv. 2015 Apr 24;86(2):E38–E48. doi: 10.1002/ccd.25566

Fig. 3 — (A) CFR revealed significant increases in the single bolus and the divided dose groups than the placebo group (*P<0.01 and **P<0.05). (B) The decreases in the perfusion defect area (%) during the follow-up correlated with the increases in CFR.

Fig. 3 — (A) CFR revealed significant increases in the single bolus and the divided dose groups than the placebo group (*P<0.01 and **P<0.05). (B) The decreases in the perfusion defect area (%) during the follow-up correlated with the increases in CFR.